General Director, Eurasia
Sanofi
Managing Director, Russia, Senior Representative, Russia and CIS
Bayer
Managing Director, Russia & CIS
Johnson & Johnson
Managing Director, Russia and CIS
Merck
General Manager, Russia and Eurasia
AstraZeneca
Vice-President, Russia
GSK
General Manager Russia and CIS
Abbott
General Manager, Russia & CIS
Eli Lilly & Company
Senior VP Cluster Head Russia, Eurasia, Turkey and MEA, General Management Russia
Teva
President
Takeda
General Manager, Eurasia & Baltics
Pfizer
General Manager, Russia
Bristol Myers Squibb
Executive Vice President, Russia and CIS
STADA
General Director
NovaMedica
General Manager
Sanofi Pasteur
President
Nanolek
General Manager
Geropharm
General Manager
Ipsen
General Manager
Abbott’s Veropharm
General Director
Erkafarm
President
Protek
General Director
Pharmacy Chain 36.6
General Director
Rigla
General Director
Protek
Retail General Director
Pharmacy Chain 36.6
Head of Region Eurasia
Bosnalijek
Chairman of the Expert Board
Institute of Public Healthcare Development
Key Account Director
Teva
Head of My Health project
Protek
Executive Director
National Pharmaceutical Chamber
Executive Director
The Union of Professional Pharmaceutical Organizations (SPFO)
Commercial Director, Russia and CIS
STADA
Quality Director, Russia and Eurasia
Teva
Market Access and Public Affairs Director, Russia & CIS
Ipsen
Head of PMO & BD&L, Cluster Russia, Ukraine & CIS, Consumer Health
Bayer
Medical Director
Ipsen
Supply Chain Manager, Russia & CIS
Merck
Market Access, Pricing and Commercial Director, Russia & CIS
Merck
Chairman
Home for Rares
Director, MA & Pricing Department
Bristol Myers Squibb
Director, Institute for Health Economics
Higher School of Economics
Market Access Director, Russia and Eurasia
AstraZeneca
Government Affairs Director
GEROPHARM
Marketing Director
GEROPHARM
Vice President, R&D
NovaMedica
Director of Corporate Communications, Eurasia
Sanofi
Senior Director Government Affairs & Market Access, Russia and Eurasia
Teva
Senior Director, Corporate Affairs, Health & Value (Market Access), Business Development
Pfizer
Pfizer
Digital Client Partner
Pfizer
Market Access Director, Russia and Belarus
Pfizer
Commercial Director, Russia
Pfizer
Head of Track & Trace, Russia and CIS
STADA
General Manager, Russia & CIS
CSL Behring
Head of Expert Consulting Centre
Institute of Public Procurement
Director
St. Petersburg Research Institute of Vaccines and Serums of the FMBA of Russia
Head of Consumer Healthcare in Eurasia zone
Sanofi
National Sales Manager, Consumer Healthcare
Sanofi
Finance Director
Bristol Myers Squibb
Market Access Director
Takeda
Pharma versus coronavirus: interviews with General Directors
General Directors of the leading companies on the market have discussed with the Russian Pharmaceutical Forum the main challenges they are facing during the pandemic, and possible approaches to collaborating with the government on developing both a vaccine and treatments for COVID-19.
The SARS-CoV-2 coronavirus pandemic has kicked the rate of development in the pharmaceutical industry into a new gear. At the early stages of the epidemic in Russia, the demand for medical masks, antiseptics and antivirals soared. A series of regulatory decisions followed, taken at an unprecedented speed, outlining a new set of rules for maximum retail prices and distance selling of medical products.
The pharmaceutical industry is undergoing enormous change fuelled by a global crisis in healthcare. But pharma also has a key role to play in the search for ways out of the current situation.
The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place
Abbott Laboratories
AbbVie
Alfa Wassermann
Allergan
Almirall
Amgen
Angelini Francesco
Baxter
Bayer Pharma
Belupo
Berlin-Chemie
Besins Healthcare
Biogen Interntional
Bittner Pharma
Boehringer Ingelheim
Boiron
Bosnalijek
Bristol-Myers Squibb
EGIS
Eisai
Eli Lilly Vostok
Galderma
Glenmark Pharmaceuticals
Hikma Pharmaceuticals
Ipsen
KRKA Pharma
Lupin
Merck
Nanolek
Novo Nordisk
Petrovax Pharm
Ranbaxy
Reckitt Benckiser
Roche
Servier
Shreya Life Sciences
26 years in the market! Russia's longest-running pharmaceutical forum
The highest profile executive-level speakers and attendees
Unrivalled networking opportunities - meet key decision makers